1. Herscovici R, Szyper-Kravitz M, Altman A, Eshet Y, Nevo M, Agmon-Levin N, et al. Superior vena cava syndrome: changing etiology in the third millennium. Lupus. 2012; 21:93–96.
2. Wan JF, Bezjak A. Superior vena cava syndrome. Emerg Med Clin North Am. 2009; 27:243–255.
3. Yu M, Shi A, Jin B, Jiang X, Liang H, Ouyang C. Superior vena cava occlusion caused by Behcet disease. J Vasc Surg. 2012; 55:1488–1491.
4. Airan B, Sharma R, Iyer KS, Kalia PK, Singh MK, Shrivastava S, et al. Malignant thymoma presenting as intracardiac tumor and superior vena caval obstruction. Ann Thorac Surg. 1990; 50:989–991.
5. Terada Y, Ono N, Noguchi T, Kamakari K, Kitano M. A case of thymoma protruding into the superior vena cava through the thymic vein. Ann Thorac Surg. 2004; 77:1088–1090.
6. Yamazaki K, Takeo S, Takeshita M, Sugimachi K. Thymic carcinoma presenting as an intraluminal growth into the great vessels and the cardiac cavity. Ann Thorac Cardiovasc Surg. 2002; 8:163–166.
7. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981; 48:2485–2492.
8. Engels EA, Pfeiffer RM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer. 2003; 105:546–551.
9. Schmidt-Wolf IG, Rockstroh JK, Schuller H, Hirner A, Grohe C, Muller-Hermelink HK, et al. Malignant thymoma: current status of classification and multimodality treatment. Ann Hematol. 2003; 82:69–76.
10. Lewis JE, Wick MR, Scheithauer BW, Bernatz PE, Taylor WF. Thymoma: a clinicopathologic review. Cancer. 1987; 60:2727–2743.
11. Tseng YL, Wang ST, Wu MH, Lin MY, Lai WW, Cheng FF. Thymic carcinoma: involvement of great vessels indicates poor prognosis. Ann Thorac Surg. 2003; 76:1041–1045.
12. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Pathology and genetics of tmours of the lung, pleura, thymus and heart. Lyon: IARC Press;2004.
13. Eguchi T, Yoshida K, Hamanaka K, Shiina T, Koizumi T, Kawakami S, et al. Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours. Eur J Cardiothorac Surg. 2012; 41:1059–1062.
14. Terzi A, Bertolaccini L, Rizzardi G, Luzzi L, Bianchi A, Campione A, et al. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms. Lung Cancer. 2011; 74:239–243.
15. Davenport E, Malthaner RA. The role of surgery in the management of thymoma: a systematic review. Ann Thorac Surg. 2008; 86:673–684.